Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance

Abeona Therapeutics IncTrade
Tencent Music Entertainment Group - ADRTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Tencent Music Entertainment Group - ADR — how do they compare? Abeona Therapeutics Inc trades at $7.4 (market cap $421.19M), while Tencent Music Entertainment Group - ADR trades at $8.36 (market cap $16.09B). The key difference: Tencent Music Entertainment Group - ADR is far larger — about 38.2× Abeona Therapeutics Inc's market cap, and Tencent Music Entertainment Group - ADR pays a 2.75% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOTME
Market Cap
$421.19M$16.09B
Sector
HealthMedia
52-Week High
$7.45$26.36
52-Week Low
$4.17$8.16
Enterprise Value
$276.10M$14.05B
Dividend Yield
2.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Abeona Therapeutics Inc

ABEO trades at $7.365, down 1.14% today, amid a bullish technical outlook with moving averages signaling strength. The company reported a net income of $71.18 million in 2025, with a net margin of 454.86%, though revenue remains modest at $5.82 million. Recent news includes CMS granting NTAP status for ZEVASKYN and expanding its treatment center network, indicating commercial progress.

The outlook is supported by strong analyst consensus (66.7% buy ratings) and robust profitability metrics, but risks include high SG&A expenses relative to revenue and a shareholder investigation. Upside hinges on revenue scaling to justify current valuations, with the Q2 2026 earnings call on August 13, 2026, as a key near-term catalyst.

Tencent Music Entertainment Group - ADR

TME stock trades at $9.90, up 3.88% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $8.9 billion (up 6% year-over-year) and net profit of $2.5 billion, beating EPS estimates. Financials show strong profitability with a net income margin of 26.28% and a P/E ratio of 10.29, indicating potential undervaluation. Recent news highlights mixed quarterly performance with revenue growth slowing but profit beating expectations.

The outlook for TME is cautiously optimistic, supported by solid fundamentals and bullish analyst sentiment, but risks include intensifying competition, user churn, and AI-related copyright issues. Upside potential exists from premium membership growth and ecosystem integration, though near-term volatility may persist due to market conditions and operational challenges.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Tencent Music Entertainment Group - ADR

TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.

Read more on TME